newsfilter
← Latest News
Business Wire·

Travere Therapeutics Announces Planned Chief Executive Officer Transition

Eric Dube, Ph.D., has decided to step down as President and Chief Executive Officer in December Following Eight Years of Exemplary LeadershipBradley L. Campbell to be Appointed President and CEO Effective December 1,